COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,941 Articles (22,604 medRxiv, 8,337 bioRxiv)

Most recent first Previous |  Page 399: Articles 3981-3990  | Next

Host-Microbiome Associations in Saliva Predict COVID-19 Severity
Alqaderi, H., Altabtbaei, K., Espinoza, J. L., Bin-Hasan, S., Alghounaim, M., Alawady, A., Altabtabae, A., AlJamaan, S., Devarajan, S., AlShammari, T., Eid, M. B., Matsuoka, M., Jang, H., Dupont, C., Freire, M.
10.1101/2023.05.02.539155 — Posted: 2023-05-03
Chronic alcohol consumption dysregulates innate immune response to SARS-CoV-2 in the lung
Lewis, S. A., Cinco, I. R., Doratt, B. M., Blanton, M. B., Hoagland, C., Davies, M., Grant, K. A., Messaoudi, I.
10.1101/2023.05.02.539139 — Posted: 2023-05-03
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV
Durstenfeld, M. S., Peluso, M. J., Spinelli, M. A., Li, D., Hoh, R., Gandhi, M., Henrich, T. J., Aras, M. A., Long, C. S., Deeks, S. G., Hsue, P. Y.
10.1101/2023.05.01.23289358 — Posted: 2023-05-02
Did knowledge, attitudes, and practices matter during the second wave of COVID-19 pandemic in Bangladesh? Results from a web-based cross-sectional study
Khan, M. R., Hossain, M. J., Islam, M. A., Zaman, S. U., Islam, M. T., Haque, M. A., Islam, M. R., Ripa, F. A., Islam, M. M., Ahmmed, F.
10.1101/2023.05.02.23289398 — Posted: 2023-05-02
COVID AMP: An Open Access Database of COVID-19 Response Policies
Katz, R., Toole, K., Robertson, H., Case, A., Kerr, J., Robinson-Marshall, S., Schermerhorn, J., Orsborn, S., Van Maele, M., Zimmerman, R., Stevens, T., COVID AMP Coding Team, , Phelan, A., Carlson, C. J., Graeden, E.
10.1101/2023.05.01.23289163 — Posted: 2023-05-02
Sex and age-dependent alterations of drug consumption during the COVID-19 lockdown in Spain: Lessons learned for the future
Lorente, J. D., Forte, A., Cuitavi, J., Verdu, F., Hipolito, L.
10.1101/2023.05.02.23289404 — Posted: 2023-05-02
Hear my Voice: Understanding how community health workers in the Peruvian Amazon expanded their roles to mitigate the impact of the COVID-19 pandemic through Community-Based Participatory Action Research
Samsamshariat, T., Madhivanan, P., Reyes, A., Moya, E., Meza, G., Reinders, S., Blas, M.
10.1101/2023.05.01.23289307 — Posted: 2023-05-02
Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy
Adhikari, E. H., Lu, P., Kang, Y. J., McDonald, A. R., Pruszynski, J. E., Bates, T. A., McBride, S. K., Trank-Greene, M., Tafesse, F. G., Lu, L. L.
10.1101/2023.05.01.538955 — Posted: 2023-05-02
Discovery and characterization of highly potent and selective covalent inhibitors of SARS-CoV-2 PLpro
Wu, J., Vaid, T., Kim, H., Lu, J., Demissie, R., Lee, H., Fung, L. W.- M., Chen, J., Xi, C., Yang, Z., Huang, Y., Zhang, Z., Zhang, J., Yan, F., Johnson, M. E., Li, M.
10.1101/2023.05.02.539082 — Posted: 2023-05-02
Computational fitness estimates of SARS-CoV-2 mutations affecting spike protein binding to antibodies and ACE2
Thakur, S., Kepp, K. P., Mehra, R.
10.1101/2023.05.01.538902 — Posted: 2023-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).